BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20826578)

  • 1. Total testosterone assays in women with polycystic ovary syndrome: precision and correlation with hirsutism.
    Legro RS; Schlaff WD; Diamond MP; Coutifaris C; Casson PR; Brzyski RG; Christman GM; Trussell JC; Krawetz SA; Snyder PJ; Ohl D; Carson SA; Steinkampf MP; Carr BR; McGovern PG; Cataldo NA; Gosman GG; Nestler JE; Myers ER; Santoro N; Eisenberg E; Zhang M; Zhang H;
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5305-13. PubMed ID: 20826578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria.
    Salameh WA; Redor-Goldman MM; Clarke NJ; Mathur R; Azziz R; Reitz RE
    Fertil Steril; 2014 Apr; 101(4):1135-1141.e2. PubMed ID: 24534279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The predictive value of total testosterone alone for clinical hyperandrogenism in polycystic ovary syndrome.
    Yang Y; Ouyang N; Ye Y; Hu Q; Du T; Di N; Xu W; Azziz R; Yang D; Zhao X
    Reprod Biomed Online; 2020 Oct; 41(4):734-742. PubMed ID: 32912651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results.
    Janse F; Eijkemans MJ; Goverde AJ; Lentjes EG; Hoek A; Lambalk CB; Hickey TE; Fauser BC; Norman RJ
    Eur J Endocrinol; 2011 Dec; 165(6):925-33. PubMed ID: 21969522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
    Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
    J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.
    Keefe CC; Goldman MM; Zhang K; Clarke N; Reitz RE; Welt CK
    PLoS One; 2014; 9(4):e93805. PubMed ID: 24713888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating testosterone concentrations in adolescent girls: Comparison of two direct immunoassays to liquid chromatography-tandem mass spectrometry.
    McCartney CR; Burt Solorzano CM; Patrie JT; Marshall JC; Haisenleder DJ
    Steroids; 2018 Dec; 140():62-69. PubMed ID: 30217784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
    Meczekalski B; Slopien R; Warenik-Szymankiewicz A
    Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry.
    Hsing AW; Stanczyk FZ; Bélanger A; Schroeder P; Chang L; Falk RT; Fears TR
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1004-8. PubMed ID: 17507629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
    Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified Ferriman-Gallwey hirsutism score and androgen levels in Turkish women.
    Coskun A; Ercan O; Arikan DC; Özer A; Kilinc M; Kiran G; Kostu B
    Eur J Obstet Gynecol Reprod Biol; 2011 Feb; 154(2):167-71. PubMed ID: 21041013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing new terminal body and facial hair growth during pregnancy: toward developing a simplified visual scoring system for hirsutism.
    Yang Y; Han Y; Wang W; Du T; Li Y; Zhang J; Yang D; Zhao X
    Fertil Steril; 2016 Feb; 105(2):494-500. PubMed ID: 26616440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Modified Ferriman-Gallwey Score and Hirsutism among Filipino Women.
    Ilagan MKCC; Paz-Pacheco E; Totesora DZ; Clemente-Chua LR; Jalique JRK
    Endocrinol Metab (Seoul); 2019 Dec; 34(4):374-381. PubMed ID: 31884737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.
    Handelsman DJ; Teede HJ; Desai R; Norman RJ; Moran LJ
    Hum Reprod; 2017 Feb; 32(2):418-422. PubMed ID: 27999117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V; Bianchi P; Balducci R; Guglielmi R; Mangiantini A; Lubrano C; Sciarra F
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.
    Mueller A; Dittrich R; Cupisti S; Beckmann MW; Binder H
    Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):182-7. PubMed ID: 16705550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin sensitivity does not differentiate by hirsutism in non-obese women with polycystic ovary syndrome.
    Cosar E; Koken G; Sahin FK; Arioz DT; Yilmazer M
    Endocr J; 2008 Jul; 55(3):465-8. PubMed ID: 18520106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome.
    Yilmaz M; Karakoç A; Törüner FB; Cakir N; Tiras B; Ayvaz G; Arslan M
    Gynecol Endocrinol; 2005 Sep; 21(3):154-60. PubMed ID: 16335907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin D treatment: A randomized placebo controlled clinical trial.
    Al-Bayyari N; Al-Domi H; Zayed F; Hailat R; Eaton A
    Clin Nutr; 2021 Mar; 40(3):870-878. PubMed ID: 33010974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone as a single agent for long-term therapy of hirsute patients.
    Spritzer PM; Lisboa KO; Mattiello S; Lhullier F
    Clin Endocrinol (Oxf); 2000 May; 52(5):587-94. PubMed ID: 10792338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.